JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2007; 49:643-656, doi:10.1016/j.jacc.2006.09.045 (Published online 25 January 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berry, C.
Right arrow Articles by Bourassa, M. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Berry, C.
Right arrow Articles by Bourassa, M. G.

Coronary Heart Disease in Patients With Diabetes

Part II: Recent Advances in Coronary Revascularization

Colin Berry, MD, PhD2, Jean-Claude Tardif, MD, FACC1 and Martial G. Bourassa, MD, FACC*

Department of Medicine, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada.


Figure 1
View larger version (10K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 1 Cumulative Survival Rates After PTCA or CABG in Diabetic and Nondiabetic Patients

Cumulative un-adjusted survival in 1,041 patients (8% with treated diabetes mellitus [DM]) who underwent coronary artery bypass grafting (CABG) between 1970 and 1985 and 702 (11% with treated DM) who underwent first percutaneous transluminal coronary angioplasty (PTCA) between 1980 and 1985. Analyses of patients after 10 to 20 years follow-up revealed survival rates in surgically treated patients to be lower than PTCA-treated patients. Reproduced from van Domburg et al. (15) with permission.

 

Figure 2
View larger version (20K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 2 Glycemic Control and Outcomes 1 Year After PCI

(A) Relationships between glycemic control and target vessel revascularization (TVR) at 12 months after elective percutaneous coronary intervention (PCI). (B) Relationships between TVR in diabetic patients treated with or without insulin and in patients without diabetes undergoing elective PCI. Reproduced from Corpus et al. (64) with permission.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2007 by the American College of Cardiology Foundation.